Melanie Cornpropst

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

John O. Link, James G. Taylor, Lianhong Xu et al. · Journal of Medicinal Chemistry · 2013 · 292 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of GS-9450 in Subjects With Nonalcoholic Steatohepatitis

Vlad Ratziu, Muhammad Y. Sheikh, Arun J. Sanyal et al. · Hepatology · 2011 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

Bruce L. Zuraw, William R. Lumry, Douglas Johnston et al. · Journal of Allergy and Clinical Immunology · 2020 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

Emel Aygören‐Pürsün, Anette Bygum, Vesna Grivcheva‐Panovska et al. · New England Journal of Medicine · 2018 · 113 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial

M. Rodríguez‐Torres, Eric Lawitz, Kris V. Kowdley et al. · Journal of Hepatology · 2012 · 106 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16